Case of bullous pemphigoid refractory to corticosteroids by antiepileptic drug-induced CYP3A4

被引：0

作者：

Asakawa, Riko ^{[1
]}

Ogawa, Youichi ^{[1
]}

Maejima, Eri ^{[1
]}

Honobe-Tabuchi, Akiko ^{[1
]}

Okamoto, Takashi ^{[1
]}

Mitsui, Hiroshi ^{[1
]}

Kagawa, Yoshiyuki ^{[2
]}

Shimada, Shinji ^{[1
]}

Kawamura, Tatsuyoshi ^{[1
]}

机构：

[1] Univ Yamanashi, Fac Med, Dept Dermatol, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan

[2] Univ Shizuoka, Sch Pharmaceut Sci, Lab Clin Pharmaceut, Shizuoka, Japan

来源：

JOURNAL OF DERMATOLOGY | 2023年 / 50卷 / 02期

关键词：

antiepileptic drugs; bullous pemphigoid; corticosteroids; METABOLISM;

D O I：

10.1111/1346-8138.16624

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The most common treatment option for patients with bullous pemphigoid is systemic corticosteroids. CYP3A4, a drug-metabolizing enzyme in the liver, metabolizes synthetic steroids to a varying degree. Although there are many CYP3A4-inducing drugs, several antiepileptic drugs, such as phenytoin and phenobarbital, strongly induce CYP3A4, thereby reducing the effects of corticosteroids. Here, we report a case of refractory bullous pemphigoid that rapidly improved after the discontinuation of phenytoin and phenobarbital. To achieve adequate pharmacological effects of corticosteroids, we must always ensure that patients who require corticosteroids for treatment are not medicated with CYP3A4-inducing agents.

引用

页码：254 / 257

页数：4

共 50 条

[21] Drug-induced enzyme activity inhibition and CYP3A4 genetic polymorphism significantly shape the metabolic characteristics of furmonertinib
Zhou, Qi
Ye, Zhize
Xu, Xiaoyu
Zhong, Yunshan
Luo, Jianchao
Zhang, Zheyan
Chen, Jing
Chen, Zhongxi
Cai, Jianping
Zhang, Xiaodan
Qian, Jianchang
TOXICOLOGY, 2024, 507
[22] Establishment of knockdown of superoxide dismutase 2 and expression of CYP3A4 cell system to evaluate drug-induced cytotoxicity
Yoshikawa, Yukitaka
Hosomi, Hiroko
Fukami, Tatsuki
Nakajima, Miki
Yokoi, Tsuyoshi
TOXICOLOGY IN VITRO, 2009, 23 (06) : 1179 - 1187
[23] A Case of Drug-induced Linear IgA Bullous Dermatosis
Dessie, Sofanit A.
Singh, Davinder
Dobariya, Varun
Evans, Derek
He, Peimei
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
[24] Drug-induced bullous pemphigoid caused by a generic Canadian medication obtained over the Internet
Ferris, LK
Jukic, D
English, JC
Zirwas, MJ
ARCHIVES OF DERMATOLOGY, 2005, 141 (11) : 1474 - 1476
[25] Comparison of CYP3A4 and CYP3A5 in Drug Metabolism and Drug Interactions
Li, Shuanmei
Liu, Duan
Zhu, Juanli
Cui, Yan
Zhou, Ruimin
Chen, Chao
DRUG METABOLISM REVIEWS, 2009, 41 : 31 - 32
[26] Comparative drug metabolism by CYP3A4 and CYP3A5
Huang, WL
Lin, YS
Dai, Y
Totah, RA
Calamia, JC
Thummel, KE
DRUG METABOLISM REVIEWS, 2003, 35 : 187 - 187
[27] Antiepileptic drugs/paracetamolLiver failure, drug-induced liver injury: 4 case reports
Reactions Weekly, 2015, 1533 (1) : 45 - 45
[28] Antiepileptic drugsHyperammonaemia and drug-induced liver injury: case report
Reactions Weekly, 2020, 1832 (1) : 40 - 40
[29] CeftriaxoneGeneralised fixed drug-induced bullous erythema: case report
Reactions Weekly, 2021, 1869 (1) : 98 - 98
[30] DRUG-INDUCED AGRANULOCYTOSIS .3. RESPONSE TO CORTICOSTEROIDS
PALVA, IP
SALOKANNEL, SJ
MUSTALA, OO
ACTA MEDICA SCANDINAVICA, 1972, 192 (1-2): : 51 - +

← 1 2 3 4 5 →